Replies to post #242756 on Biotech Values

[RNsidersbuying]

RIGL .95 - also looks like they'll need to raise capital any day now...as their covid therapeutic advancement trials fizzle out.

Q1 Loss = (27,445)

Shareholder Equity = 6,798

https://docoh.com/filing/1034842/0001104659-22-055272/RIGL-8K/file/2